Clinical Trial Update: Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients [Phase 3]

View source ↗

Summary

Phase 3 TELFIT study assessing reinforcement of functional insulin therapy training via telemonitoring with a PDA-phone in Type 1 Diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED